19 June 2013
Keywords: millennium, starts, ph, ii, velcade, trial, crc
Article | 06 January 2003
Millennium Pharmaceuticals has started a Phase II trial of itsproteasome inhibitor Velcade (bortezomib) in patients with colorectal
cancer. The company ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 January 2003
18 June 2013
© 2013 thepharmaletter.com